Risk of cancer in patients with inflammatory bowel disease and venous thromboembolism: A nationwide cohort study
✍ Scribed by Gitte Vrelits Sørensen; Rune Erichsen; Claus Sværke; Dóra Körmendiné Farkas; Henrik Toft Sørensen
- Book ID
- 112101275
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 81 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: Incidences of inflammatory bowel disease (ibd) and of breast cancer have increased over the last decades. the influence of ibd on breast cancer prognosis, however, is unknown. we therefore examined the impact of ibd on treatment receipt and survival in breast cancer patients. ## Met
Background: Immune suppressant medications such as thiopurines and anti-tumor necrosis factor agents are important for maintaining disease control in most patients with inflammatory bowel diseases (IBDs); however, their use has been associated with the development of malignant lymphoma. The purpose